Laboratory studies show that Merck's experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant, highly transmissible Delta, the company said. Works by introducing errors into the genetic code of the virus.

submitted by Orangutan from finance.yahoo.com

sorted by:
top
newinsightfulfun
you are viewing a single comment's thread.

view the rest of the comments →

[–]iamonlyoneman 2 insightful - 1 fun2 insightful - 0 fun3 insightful - 1 fun -  (3 children)

Is this the one that works by the same action as ivermectin does?

[–]Bigs 3 insightful - 4 fun3 insightful - 3 fun4 insightful - 4 fun -  (2 children)

No, this one works by being mutagenic, to give covid cancer....

What could poffibly go wong?

[–]Rah 3 insightful - 2 fun3 insightful - 1 fun4 insightful - 2 fun -  (1 child)

Im sure they did everything possible to just affect the virus, just as the vaccines also do, right? Its not like they cant be sued for damage or they lied before to us, right?

[–]Bigs 2 insightful - 1 fun2 insightful - 0 fun3 insightful - 1 fun -  (0 children)

Interestingly enough, such a drug would not have the same protections against liability as a vaccine, right..?